Skip to content
Close menu


NHS Cancer Programme Innovation open call 1

NHS Cancer Programme Innovation open call 1 Selection panel

Professor Nick Lemoine (Chair)
Director, Barts Cancer Institute
Among other commitments, Professor Lemoine is the Chair of Trustees for the Medical Research Foundation (the MRC’s independent charity), Chair of Trustees for the Global Alliance for Chronic Diseases and Chair of Trustees for the Africa Research Excellence Fund. He is also Chair of the Research Advisory Board for the Pancreatic Cancer Research Fund, as well as Chair of the NIHR i4i Challenge Awards committee.

Dr Neville Young (Deputy Chair)
Director of Enterprise and Innovation, Yorkshire and Humber AHSN
Dr Young holds a PhD in molecular embryology and is experienced with innovative surgical tools, intraoperative imaging systems, novel biosensing diagnostics, nanotechnology and remote monitoring.

Professor Richard Gilbertson
Li Ka Shing Chair of Oncology, Head of Department of Oncology, Director CRUK Cambridge Major Centre, University of Cambridge
Gilbertson, a clinician scientist, has expertise in childhood brain tumour biology and treatment and the executive management of large US and UK academic health-science organisations.

Professor Emma Crosbie
Professor and Honorary Consultant in Gynaecological Oncology, University of Manchester
Screening, prevention and early detection of gynaecological cancers.

Dr Christina Messiou
Consultant Radiologist
Oncological imaging, digital health and AI applied to imaging but with broader experience as lead of the digital theme of the RMH/ICR NIHR BRC.

Dr Rosie Loftus
Chief Medical Officer, The Royal Marsden NHS Trust & Institute of Cancer Research
GP Principal in Kent from 1989. Macmillan GP from 2001 and Lead GP Adviser 2003-2013. Appointed Macmillan Joint CMO in 2014 and CMO since 2018.

Professor Rachel Butler
Consultant Clinical Scientist, Operational Director, SW Genomics Laboratory Hub
Professor Butler is an NHS genomic scientist with considerable experience in the translation and implementation of novel assay s for cancer diagnostics.

Ms Elaine Warburton
Co-Founder and Non-Executive Director, QuantuMDx Group Ltd
Elaine is a health and diagnostic specialist with expertise in developing and responsibly commercialising novel solutions that help to alleviate global healthcare problems.

Mr Steven Morris
Founder and Visiting Professor, Ingram Network Ltd and Bangor University
Mr Morris has led project teams for the Ministry of Defence and delivery major projects for the Royal Navy and the British Army, a co-founder and the Chief Operating Officer of Creo Medical Ltd from 2009 to 2019, which produced CE marked and FDA-cleared products on sale in major global markets.

Dr Gareth King
Life Science Partner, Catapult Ventures
A scientist (University of Edinburgh, Harvard Medical School, AstraZeneca), who moved into business development (Incyte, Cyprotex, Quotient) and became a CEO (Critical Pharmaceuticals) and investor (Catapult Ventures).

Mr Mark Campbell
Freelance Consultant, Independent Expert
Mr Campbell is an independent healthtech consultant who, until 2019, was responsible for NICE’s medtech evaluation programmes. He has also worked at Director level in an NHS commissioning organisation.

Professor John Hutton
Non-Executive Director, Medipex
Formerly Professor at the University of York and NHS Trust Non-Executive. John has over 35 years’ experience of research, teaching and consulting in health economics and health technology assessment.

Professor Sam Shah
Director and Founder, Faculty of Future Health, University of Ulster
Professor Shah has expertise in digital development of the ecosystem, public health, health policy and digital transformation, and experience in health education and commissioning of services.

Dr Emma Kipps
Clinical Director, Medical Oncologist, RM Partners, Royal Marsden NHS Foundation Trust
Dr Kipps is the Clinical Director of RM Partners and is a Medical Oncologist in Breast Cancer.

Professor Andrée Le-May
Joint Implementation Lead, University of Southampton, Eat of England Applied Research Collaboration
Andrée’s expertise lies largely within the fields of implementation, qualitative and participatory research, service development and nursing education.

John Marshall (PPI)
Patient advocate
John Marshall is a recovered prostate cancer patient and retired nuclear engineer and safety/environmental regulator. He has extensive experience in managing research into prostate cancer where he acts as a lay and patient member of the advisory committees on developing health policies and research options.

Alero Dabor (PPI)
Public Committee member, NIHR
Alero Dabor is a breast cancer survivor and advocate. She has extensive experience of patient and public involvement, where the focus is around her added value and insights to research through lived experience. She trains and acts as a facilitator for research methods, advising both researchers and public contributors.


Subscribe to the SBRI Healthcare newsletter and receive the latest competition information & latest news updates.